NCT06907238View on ClinicalTrials.gov

The Value of Novel Thrombus Markers in the Diagnosis and Treatment of Acute Pulmonary Embolism

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

October 14, 2025

Primary Completion Date

July 30, 2027

Study Completion Date

December 31, 2027

Conditions

Acute Pulmonary Embolism

All Listed Sponsors

lead

Beijing Anzhen Hospital

OTHER

NCT06907238 - The Value of Novel Thrombus Markers in the Diagnosis and Treatment of Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter